“Psychedelics are potent psychoactive chemicals or plants that can alter perception, mood, and cognitive processes. Some of the most common psychedelics include psilocybin (found in certain mushrooms), LSD, mescaline (found in San Pedro and peyote cacti), ayahuasca (a brew containing a woody vine and the leaves of the chacruna plant), and DMT (dimethyltryptamine).
Mind-altering psychedelic plants naturally grow as far afield as the Amazon, the Himalayas, and the Pacific Northwest of the US.
Psychedelics aren’t a new fad. Their use predates the written word, with archaeologists confirming their use in ancient ritual and ceremonial contexts. While the ingestion of psychedelics for recreational and sacred purposes has been ongoing, their therapeutic potential was first recognized by scientists in the mid-20th century.
Between 1950 and the mid-’60s, more than 1,000 clinical papers were published on psychedelic drug therapy, spearheaded by researchers awed by the assorted medical benefits these compounds could potentially offer.
The introduction of the Controlled Substances Act in 1970 saw psychedelics research slow to a trickle as government-sanctioned research ceased, and the compounds became tarred by the war on drugs.
Fast forward to the present day, and studies into this fascinating compound have picked up momentum again. Scientists are delving back into psychedelic research, exploring the myriad ways this unique medicine may help heal diverse ills. Recent research has shown promise in using psychedelics to treat substance dependency, PTSD, depression, anxiety, and to help with end-of-life care.”